Dr Willmar Schwabe India Private Limited

Dr Willmar Schwabe India Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1994PTC057707 Incorporated 04 March 1994 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Medium
Revenue · FY 2022
₹284.52 Cr
▲ 10% YoY
Authorised capital
₹185 Cr
Registered with MCA
Paid-up capital
₹19.13 Cr
Issued & subscribed
Satisfied charges
₹3.6 Cr
No open charges
Company age
32 yrs
Est. 1994
Employees · EPFO
814
Provident fund records
Directors on board
7
As per MCA filings
Active GSTINs
9
of 12 registered

About Dr Willmar Schwabe India Private Limited

Data last updated:

Dr Willmar Schwabe India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Schwabe International Se, Germany. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 March 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC057707. Its GSTIN is 07AAACD0463D2Z7 (Delhi). The company holds 12 GST registrations, of which 9 are active.

The company has an authorised share capital of ₹185 Cr and a paid-up capital of ₹19.13 Cr. It is led by directors including Ashish Kumar (Managing Director) and Dr Anke Herta Balzer.

Its last annual general meeting (AGM) was held on 25 June 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at H – 36 Green Park Extension, New Delhi, Delhi, India – 110016.

As per the financials filed for FY 2022, the company reported a revenue of ₹284.52 Cr, a growth of 10% compared to the previous year. Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 19% over five years.

The company has about 814 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: Schwabe India and Sanat Products. As per MCA filings, the company has satisfied charges of ₹3.6 Cr on record. Court records list 46 cases involving the company, including 27 filed by the company and 19 filed against it; 12 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2017. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Gracure Pharmaceuticals Limited with revenue of ₹287.44 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2023, listing 737 overdue payments to 73 micro and small suppliers.

Dr Willmar Schwabe India Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-28-0039039). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website schwabeindia.com.

Company details

CIN U74899DL1994PTC057707
Registration Number 057707
Incorporation Date 04 March 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Parent Company Schwabe International Se, Germany
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UP-28-0039039

Recognitions & Rankings of Dr Willmar Schwabe India

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-UP-28-0039039

Contact details

Dr Willmar Schwabe India Private Limited's registered office is in New Delhi, Delhi. Its website is schwabeindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Apps
  • Registered Address
    H – 36 Green Park Extension, New Delhi, Delhi, India – 110016
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dr Willmar Schwabe India Private Limited, buy the company report.

Comprehensive company report
Dr Willmar Schwabe India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dr Willmar Schwabe India operates two associated brands: Schwabe India and Sanat Products. Each brand links to its own profile.

BrandDescriptionWebsite
Homeopathic medicine manufacturing and online retail in India.schwabeindia.com
Herbal extracts and pharmaceutical products manufacturing in India.hindustanherbals.org

Financials of Dr Willmar Schwabe India Private Limited

FY 2024 filings available

Dr Willmar Schwabe India Private Limited reported revenue of ₹284.52 Cr (up 10% YoY) for FY 2022.

Revenue · FY 2022
₹284.52 Cr ▲ 10%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 23%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 10% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dr Willmar Schwabe India Private Limited, buy the company report.

Board of directors of Dr Willmar Schwabe India Private Limited

Dr Willmar Schwabe India has 7 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Akhilesh Kumar TripathiAlternate Director11 Dec 20250 Years 11 MonthsCurrent
Ashish KumarManaging Director07 Nov 201115 Years 0 MonthsCurrent
Dr Anke Herta BalzerDirector01 Oct 20197 Years 1 MonthsCurrent
Dr Frank WaimerDirector01 Feb 20242 Years 9 MonthsCurrent
Joachim August TholeDirector01 Feb 20242 Years 9 MonthsCurrent
Patrick KrauthDirector01 Feb 200521 Years 9 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Dr Willmar Schwabe India Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Gracure Pharmaceuticals Limited₹287.44 Cr (FY 2025)27.0%New Delhi, Delhi, India
Pinnacle Life Science Private Limited₹286.72 Cr (FY 2023)-2.0%Baddi, Himachal Pradesh, India
Sava Healthcare Limited₹284.97 Cr (FY 2025)14.0%Wadhwan, Gujarat, India
Med Manor Organics Private Limited₹284.93 Cr (FY 2025)5.0%Hyderabad, Telangana, India
Dr Willmar Schwabe India Private Limitedthis company₹284.52 Cr (FY 2022)10.0%814New Delhi, Delhi, India
Amanta Healthcare Limited₹276.09 Cr (FY 2025)-2.0%Ahmedabad, Gujarat, India
Amn Life Science Private Limited₹273.11 Cr (FY 2025)42.0%Mumbai, Maharashtra, India

To see the full peer comparison of Dr Willmar Schwabe India Private Limited, buy the company report.

Auditor

Dr Willmar Schwabe India Private Limited is audited by Deepak K Kejrewal & Co. for the financial year 2021.

Auditor firmFinancial yearFirm registration number
Deepak K Kejrewal & Co.FY 2021011919N

Shareholding

The shareholding of Dr Willmar Schwabe India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dr Willmar Schwabe India Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹3.6 Cr
Breakdown by lending institutions
Deutsche Bank₹3.60 Cr
Dresdner Bank Ag₹0.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
08 Mar 199990053539Dresdner Bank Ag₹-Satisfied
29 Jan 199890053250Deutsche Bank₹3.6 CrSatisfied

To see the full charge records of Dr Willmar Schwabe India Private Limited, buy the company report.

Total charge records: 2 View all charges

Deals & funding

Dr Willmar Schwabe India Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2017.

Total deals
2
Secondary share transfers
2

Deals on record (2 of 2)

WhenDealAmountParties
Mar 2017Secondary share transferUndisclosedSeller: Schwabe International Gmbh
Mar 2010Secondary share transferUndisclosedBuyer: Schwabe International Gmbh
Seller: Kamlesh Gupta Huf, R K Imports Private Limited, Homeopathic Distributers Limited, an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Dr Willmar Schwabe India Private Limited has 14 MSME Form 1 returns on record between 2019 and 2023, listing 737 overdue payments to 73 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 73)

SupplierAmount dueDue sinceReported on
Bacfo Pharmaceuticals (India ) Limited
an individual supplier
an individual supplier
Aar Reprographics
Biogenix Systems Private Limited

To see the full MSME payment records of Dr Willmar Schwabe India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Dr Willmar Schwabe India Private Limited has a workforce of 814 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
814
Active EPFO establishments
2
Employee growth
-36%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27814
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17
FY 2015-16
FY 2014-15
FY 2013-14
FY 2012-13

To see the full employee and EPFO history of Dr Willmar Schwabe India Private Limited, buy the company report.

GST

Dr Willmar Schwabe India has 12 GST registrations: 9 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
12
Active
9
Cancelled / inactive
3
GSTINStateStatusRegistered on
07AAACD0463D2Z7DelhiActive04 Oct 2021
09AAACD0463D1Z4Uttar PradeshActive01 Jul 2017
10AAACD0463D1ZLBiharActive01 Jul 2017
19AAACD0463D1Z3West BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Dr Willmar Schwabe India Private Limited, buy the company report.

Recent activity

Dr Willmar Schwabe India Private Limited has 16 board changes on record since 2005: 7 appointments and 9 cessations. The latest: Akhilesh Kumar Tripathi was appointed as Alternate Director on 11 Dec 2025.

Appointed
Akhilesh Kumar Tripathi was appointed as Alternate Director.
Appointed
Vikram Grover was appointed as Alternate Director.
AGM
Dr Willmar Schwabe India Private Limited last Annual general meeting of members was held on 25 Jun 2025 as per latest MCA records.
Filing
Dr Willmar Schwabe India Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Delhi.
Appointed
Dr Frank Waimer was appointed as Director.
Appointed
Joachim August Thole was appointed as Director.
Charges
A charge registered on 29 Jan 1998 via Charge ID 90053250 with Deutsche Bank was fully satisfied on 07 Sep 2020.
Appointed
Dr Anke Herta Balzer was appointed as Director.
Ceased
Peter Rudolf Braun ceased to be Director.
Ceased
Akhilesh Kumar Tripathi ceased to be Alternate Director.
Ceased
Vikram Grover ceased to be Alternate Director.
Ceased
Rainer Skrotzki ceased to be Director.

12 earlier events are in the company report.

Frequently asked questions

Dr Willmar Schwabe India is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 March 1994 (32+ years old) and is registered under CIN U74899DL1994PTC057707.

Dr Willmar Schwabe India has 7 current directors:

The latest financial statements of Dr Willmar Schwabe India on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 25 June 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dr Willmar Schwabe India is 07AAACD0463D2Z7, registered in Delhi. The company has 12 GST registrations in all, of which 9 are active and 3 are cancelled or inactive. Other active GSTINs include 09AAACD0463D1Z4 (Uttar Pradesh), 10AAACD0463D1ZL (Bihar), 19AAACD0463D1Z3 (West Bengal).

The CIN (Corporate Identification Number) of Dr Willmar Schwabe India is U74899DL1994PTC057707. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dr Willmar Schwabe India has 46 court cases on record: 27 filed by the company and 19 filed against it. 12 are pending. Most are in the district courts.

Dr Willmar Schwabe India was incorporated on 04 March 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.

Dr Willmar Schwabe India has 2 deals on record (2 secondary share transfers); the latest was in March 2017.

The peers of Dr Willmar Schwabe India by revenue are Gracure Pharmaceuticals Limited, Pinnacle Life Science Private Limited, Sava Healthcare Limited, Med Manor Organics Private Limited, Amanta Healthcare Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Akhilesh Kumar Tripathi was appointed as Alternate Director on 11 Dec 2025. Vikram Grover was appointed as Alternate Director on 11 Dec 2025. Dr Frank Waimer was appointed as Director on 01 Feb 2024. Dr Willmar Schwabe India has 16 board changes on record in total.

Yes, Dr Willmar Schwabe India is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-28-0039039).

Dr Willmar Schwabe India has 14 MSME Form 1 returns on record between 2019 and 2023, listing 737 overdue payments to 73 micro and small suppliers. The latest return was filed on 02 Mar 2024.